Method and apparatus for treating refractive error of the eye

Information

  • Patent Grant
  • 12226647
  • Patent Number
    12,226,647
  • Date Filed
    Friday, May 3, 2019
    6 years ago
  • Date Issued
    Tuesday, February 18, 2025
    2 months ago
Abstract
A source of light energy such as a source of violet light energy is coupled to a structure configured to contact the eye. The light source and structure are arranged to provide therapeutic amounts of violet light energy to the eye in order to inhibit the progression of refractive error such as myopia. The light source can be configured in many ways and may comprise a radioisotope and a phosphorescent material. The structure configured to contact the eye may comprise a contact lens or an implant.
Description
BACKGROUND

Prior approaches to vision correction of refractive error of the eye are less than ideal in at least some respects. Although spectacles and contact lenses can correct vision, these corrective devices may not decrease the onset and severity of myopia and other refractive errors. Similarly, most surgical approaches do not address the underlying causes of ocular development that can result in the eye having refractive error.


In light of the above, improved methods and apparatus of treating refractive error of the eye are needed. Ideally, such methods and apparatus would at least partially address the progression and onset of refractive error of the eye such as myopia.


SUMMARY

Embodiments of the present disclosure provide improved methods and apparatus for the treatment of refractive error with light, such as violet light. In some embodiments, a source of light energy such as a source of violet light energy is coupled to a structure configured to contact the eye. The light source and structure are arranged to provide therapeutic amounts of light such as violet light energy to the eye in order to inhibit the progression or onset of refractive error such as myopia. The light source can be configured in many ways and may comprise a radioisotope and a phosphorescent material. The structure configured to contact the eye may comprise a contact lens or an implant.


In a first aspect, an apparatus to treat refractive error of an eye comprises a structure to contact the eye, and a light source coupled to the structure. The light source is configured to direct light energy toward a retina of the eye to treat the refractive error of the eye.


In some embodiments, the light source emits violet light.


In some embodiments, the structure comprises a contact lens, and optionally the light source is one or more of embedded in the contact lens, located on an anterior surface of the contact lens, or located on a posterior surface of the contact lens.


In some embodiments, the light energy comprises violet light energy comprising a wavelength within a range from about 360 nm to about 400 nm.


In some embodiments, the light energy comprises violet light energy and the light source is configured to direct the violet light energy to the retina with an irradiance within a range from about 0.1 mW/cm2 to 5 mW/cm2.


In some embodiments, the light source illuminates a pupil of the eye with light energy in the range 0.1 nit to 10 nits and optionally within the range from 0.5 nits to 10 nits.


In some embodiments, the contact lens comprises one or more of a structure anterior to the light source to reflect light to the retina of the eye, a structure posterior to the light source to focus light onto the retina of the eye, a lens structure posterior to the light source to focus light onto the retina of the eye, or a diffractive structure posterior to the light source to diffract light toward the retina of the eye.


In some embodiments, the contact lens comprises a lens body, the lens body comprising one or more of a soft contact lens, a hydrogel contact lens, a hard contact lens, a rigid gas permeable contact lens, a polymethyl methacrylate contact lens, or an orthokeratology contact lens.


In some embodiments, the light energy comprises light energy violet light energy and the contact lens is configured to direct the violet light energy onto a cornea and toward the retina with an amount sufficient to promote a curvature change to the cornea of the eye.


In some embodiments, the structure comprises a contact lens comprising a posterior surface comprising a posterior radius of curvature sized to fit a cornea of the eye, and an anterior surface comprising an anterior radius of curvature configured to correct vision of the eye, and optionally the anterior surface comprises a second anterior radius of curvature oriented in relation to the anterior radius of curvature to correct an astigmatism of the eye.


In some embodiments, the structure to contact the eye comprises an implantable structure and the implantable structure comprises a covering disposed over the light source, and optionally the implant is configured to be turned on and off by a person who received the implant.


In some embodiments, the light source comprises one or more of a radioluminescent light source, a light emitting diode, a laser diode, a radioactive material, or a phosphorescent material, and optionally the radioactive material comprises tritium or radium.


In some embodiments, the structure to contact the eye comprises an optically transmissive material comprising a transmittance of at least 40% at 360 nm.


In some embodiments, the light source is arranged in a pattern on the structure to contact the eye, the pattern comprising one or more of: a spatial pattern on the structure to contact the eye, a spatial pattern located on an optically used portion of a contact lens, a spatial pattern on an inner portion of the contact lens to transmit light to the retina when the pupil constricts, a circular pattern, or a radial pattern, and optionally the structure to contact the eye comprises a contact lens.


In some embodiments, the apparatus comprises a contact lens comprising a posterior surface shaped to receive a cornea of the eye, a contact lens material comprising an index of refraction configured to transmit violet light from the source toward the retina, the contact lens comprising an anterior surface shaped to correct a refractive error of the eye in combination with the index of refraction and the posterior surface, and optionally the contact lens is configured to correct higher order aberrations comprising optical aberrations above third order, and optionally the contact lens comprises a multifocal contact lens configured to correct presbyopia.


In another aspect, a method comprises treating an eye with the apparatus of any one of the preceding claims.


INCORPORATION BY REFERENCE

All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.





BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:



FIG. 1A shows a contact lens configured to treat refractive error of the eye in a cross-sectional view, in accordance with some embodiments.



FIG. 1B shows a front view of the contact lens of FIG. 1A.





DETAILED DESCRIPTION

The methods and apparatus disclosed herein are well suited for combination with prior approaches to vision correction. For example, the structure to contact the eye may comprise a contact lens or an implant. Such structure may function normally to correct refractive errors and focus light into the eye, while the light source coupled to the structure may emit light such as violet light toward a retina of the eye to treat the refractive error of the eye. In some embodiments, such emission of violet light and violet light received by the eye may be controlled at a level so that there may not be noticeable influence on the functions of the eye.


In some embodiments, the apparatuses and methods disclosed herein are configured to prevent progression or onset of refractive errors in the eye(s). In some embodiments, the apparatuses and methods disclosed herein are configured to treat or improve refractive conditions in the eye(s). In some embodiments, the apparatuses and methods herein promote a curvature change to the cornea of the eye thereby improving refractive conditions in the eye(s), for example with orthokeratology assisted by light such as violet light. In some embodiments, the apparatuses and methods herein inhibit inappropriate increases or allow controlled amounts of increase to the axial length of the eye thereby reducing refractive errors in the eye(s) such as myopia.


In some embodiments, an apparatus to treat refractive error of an eye comprises: a structure to contact the eye; a light source coupled to the structure; wherein the light source is configured to emit violet light energy toward a retina of the eye to treat the refractive error of the eye. In some embodiments, the structure comprises a contact lens. The light source can be embedded in the contact lens, on an anterior surface of the contact lens, or on a posterior surface of the contact lens and combinations thereof. In some embodiments, the violet light comprises a wavelength within a range from about 360 nm to about 400 nm. In some embodiments, the light source is configured to direct violet light energy to the retina with a luminance is less than 5 mW/cm2. In some embodiments, the light source illuminates the pupil of the eye with light energy in the range from 0.1 nit to 10 nit (candelas per square meter), preferably from 0.5 nit to 2 nits. In some embodiments, the contact lens comprises a structure anterior to the light source to reflect light to the retina of the eye, a structure posterior to the light source to focus light onto the retina of the eye, a lens structure posterior to the light source to focus light onto the retina of the eye, or a diffractive structure posterior to the light source to diffract light toward the retina of the eye, and combinations thereof. In some embodiments, the contact lens comprises a lens body, in which the lens body comprises a soft contact lens, a hydrogel contact lens, a hard contact lens, a rigid gas permeable contact lens, a polymethyl methacrylate contact lens, or an orthokeratology contact lens, and combinations thereof. In some embodiments, the contact lens is configured to direct the violet light energy onto a cornea and toward the retina with an amount sufficient to promote a curvature change to the cornea of the eye. In some embodiments, the structure comprises a contact lens comprising a posterior surface comprising a posterior radius of curvature sized to fit a cornea of the eye, and an anterior surface comprising an anterior radius of curvature configured to correct vision of the eye. In some embodiments, the anterior surface comprises a second anterior radius of curvature oriented in relation to the anterior radius of curvature to correct an astigmatism of the eye.


In some embodiments, the structure to contact the eye comprises an implantable structure, in which the implantable structure comprises a covering disposed over the light source. The implant can be configured to be turned on and off by a person who received the implant.


The light source can be configured in many ways. In some embodiments, the light source comprises a radioluminescent light source, a light emitting diode, a laser diode, a radioactive material, or a phosphorescent material and combinations thereof. The radioactive material may comprise tritium or radium, for example.


In some embodiments, the structure to contact the eye comprises an optically transmissive material comprising a transmittance of at least 40% at 360 nm.


In some embodiments, the light source is arranged in a spatial pattern on the structure to contact the eye. The spatial pattern can be located on an optically used portion of a contact lens, on an inner portion of the contact lens to transmit light to the retina when the pupil constricts, or in a circular pattern or a radial pattern on the contact lens, and combinations thereof.


In some embodiments, the apparatus comprises a contact lens comprising a posterior surface shaped to receive a cornea of the eye, a contact lens material comprising an index of refraction and configured to transmit violet light from the source toward the retina, an anterior surface shaped to correct a refractive error of the eye in combination with the index of refraction and the posterior surface. In some embodiments, the contact lens is configured to correct higher order aberrations comprising optical aberrations above third order, and the contact lens may comprise a multifocal contact lens configured to correct presbyopia.


In some embodiments, a method of treating the eye comprises treating an eye with the apparatus(es) as disclosed herein, such as a contact lens or an implant as disclosed herein.


Referring to FIGS. 1A to 1B, in accordance with some embodiments, the apparatus 100 comprises a structure to contact the eye 101. In some embodiments, the structure 101 comprises a contact lens or an intraocular lens (IOL). In some embodiments, the contact lens 101 includes a lens body. Nonlimiting examples of the lens body include a soft contact lens, a hydrogel contact lens, a hard contact lens, a rigid gas permeable contact lens, a polymethyl methacrylate contact lens, or an orthokeratology contact lens, and combinations thereof. In some embodiments, the contact lens has a posterior surface 101b comprising a posterior radius of curvature sized to fit a cornea of the eye, and an anterior surface 101a comprising an anterior radius of curvature configured to correct vision of the eye. In some embodiments, the anterior surface also includes a second anterior radius of curvature oriented in relation to the anterior radius of curvature to correct astigmatism of the eye. In some embodiments, the contact lens material has an index of refraction and is configured to focus violet light from the source toward the retina. In some embodiments, the anterior surface 101a is shaped to correct a refractive error of the eye (e.g., myopia, hyperopia, presbyopia, and astigmatism) with a combination of the index of refraction and the posterior surface 101b. In some embodiments, the contact lens is configured to correct higher order aberrations comprising optical aberrations of third order, e.g. coma, and above, e.g. spherical aberration. In some embodiments, the contact lens comprises a multifocal contact lens configured to correct presbyopia.


In some embodiments, the contact lens material has an index of refraction and is configured to transmit violet light from the source toward the retina. In some embodiments, the structure to contact the eye 101 has an optically transmissive material comprising a transmittance of at least 30%, 40%, 50%, or 60% at one or more of 350 nm, 360 nm, 370 nm, 380 nm, 390 nm, or 400 nm. In some embodiments, the transmittance is at least 30%, 40%, 50%, or 60% in the entire range from 350 nm to 400 nm.


In some embodiments, the apparatus 100 includes the light source 102 that is coupled to the structure 101. The light source 102 may comprise a plurality of light sources. In some embodiments, the light source is embedded in the structure, and the light source may be embedded in one or more locations of the structure. Such locations may include the optically used portion of the lens. For example, the light source can be located anywhere on an anterior surface 101a of the contact lens 101, or on a posterior surface 101b of the contact lens and combinations thereof. In some embodiments, the light source may be spatially distributed in various patterns. In some embodiments, the spatial pattern may be located on an optically used portion of a contact lens, on an inner portion of the contact lens, or both, to transmit light to the retina (e.g., when the pupil constricts). In some embodiments, the light source may be distributed or in a circular pattern or a radial pattern on the contact lens, and combinations thereof. As shown in FIG. 1B, the light source may be distributed in multiple concentric rings with fixed or variable gaps therebetween. In some embodiments, the light source may be distributed in a donut pattern. Nonlimiting examples of patterns in which the light source may be spatially distributed include: a web-like pattern, a spiral pattern, a swirl pattern, and a radially scatter pattern (optionally from the center of the structure). In some embodiments, the spatial pattern may include areas that are at or substantially at the circumference of the structure (e.g., less than 3 mm, 2 mm, 1 mm, 0.5 mm, 0.2 mm or less to the circumference). As an example, the light source includes multiple concentric rings with a largest ring covering the entire circumference.


In some embodiments, the light source is configured to emit optical energy toward a retina of the eye to treat the refractive error of the eye. As shown in FIGS. 1A and 1B, the light source emits violet light toward the eye. FIG. 1A shows the cross section at A-A′ in FIG. 1B. The violet light may comprise a wavelength within a range from about 350 nm to about 400 nm. In some embodiments, the light source is configured to direct violet light energy to the retina with a radiance less than 5 mW/cm2. The radiance of the violet light can be within a range from about 0.01 mW/cm2 to about 5 mW/cm2, for example. Continuing to refer to FIGS. 1A-1B, in some embodiments, the contact lens 101 has a structure 103 anterior to the light source to reflect light to the retina of the eye. Alternatively or in combination, a structure 104 can be located posterior to the light source 102 in order to focus light onto the retina of the eye. The structure 104 may comprise a lens structure posterior to the light source to focus light onto the retina of the eye, or a diffractive structure posterior to the light source to diffract light toward the retina of the eye, and combinations thereof. Alternatively or in combination, the light source can be located closer to the posterior surface of the lens than the anterior surface in order to decrease absorbance of the contact lens material.


In some embodiments, the structure to contact the eye 101 comprises an implantable structure which may comprise a covering disposed over the light source and optionally wherein the implant is configured to be turned on and off, for example, by a person who received the implant or by a trigger external to the implant such as intensity of ambient light detected by the implant.


In some embodiments, the contact lens 101 or the implant is configured to direct the violet light energy onto a cornea and toward the retina with an amount sufficient to promote a curvature change to the cornea of the eye. In some embodiments, the light source is configured to emit the light at a substantially constant level (e.g. within 25%) for a pre-determined period of time, e.g., for at least 12 hours, 1 day, 1 week, 2 weeks, 1 month, or even longer. In some embodiments, the light source is configured to emit the light when triggered by an external trigger. Non-limiting exemplary triggers may include ambient light, opening or closing of the eyelid, a temperature at the light source, etc. In some embodiments, the light source is configured to remain substantially fixed in its spatial location relative to the eye of the patient.


In some embodiments, the light source 102 is configured to direct violet light energy to the retina with a luminance. The light source may have a radioluminescent light source, a light emitting diode, a laser diode, a radioactive material, a phosphorescent material, or a chemiluminescent compound, and combinations thereof. In some embodiments, the radioactive material includes tritium and/or radium.


In some embodiments, the irradiance (energy per unit area) of the violet light (e.g., having a wavelength within the range of 350 nm to 400 nm) emitted from the light source and/or that reaches the eye is not particularly limited. In some embodiments, the irradiance is preferably determined by taking into consideration the effect of the on the human eye and skin, and the duration of the exposure. When light is emitted toward the eye for a long period of time for the purpose of myopia prevention, the irradiance relates to the light emission time as well, and may be increased if the time is short, but is preferably decreased if the time is long. In some embodiments, the irradiance may be 20.0 mW/cm2 or less. In some embodiments, the irradiance may be 10.0 mW/cm2 or less. In some embodiments, the irradiance may be 80.0 mW/cm2 or less. In some embodiments, the irradiance may be 5.0 mW/cm2 or less. In some embodiments, the preferred irradiance is 3.0 mW/cm2 or less. In some embodiments, the irradiance is preferably 2.0 mW/cm2 or less, and is preferably decreased to 1.0 mW/cm2, 0.5 mW/cm2 or less, 0.1 mW/cm2 or less, or 0.05 mW/cm2 or less as the time increases. The irradiance may comprise an amount within a range defined by any two of the preceding values. The irradiance can be measured using a known method. It should be noted that “irradiance” indicates the intensity or energy of the light that enters or reaches the eye.


In some embodiments, the structure to contact the eye includes apiece of eyewear such as an eyeglass, or a goggle.


The presently disclosed methods and apparatus are well suited for combination with many types of lenses, such as one or more of: smart contact lenses, contact lenses with antennas and sensors, contact lenses with integrated pulse oximeters, contact lenses with phase map displays, electro-optic contact lenses, contact lenses with flexible conductors, autonomous eye tracking contact lenses, electrochromic contact lenses, dynamic diffractive liquid crystal lenses, automatic accommodation lenses, image display lenses with programmable phase maps, lenses with tear activated micro batteries, tear film sensing contact lenses, lenses with multi-colored LED arrays, contact lenses with capacitive sensing, lenses to detect overlap of an ophthalmic device by an eyelid, lenses with active accommodation, lenses with electrochemical sensors, lenses with enzymes and sensors, lenses including dynamic visual field modulation, lenses for measuring pyruvate, lenses for measuring urea, lenses for measuring glucose, lenses with tear fluid conductivity sensors, lenses with near eye displays with phase maps, or lenses with electrochemical sensor chips.


While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.

Claims
  • 1. An apparatus to treat refractive error of an eye, comprising: a first structure configured to contact an anterior surface of the eye, the first structure comprising a refractive lens shaped to correct a refractive error of the eye;a light source coupled to the first structure;a second structure on the first structure to focus a light energy from the light source toward a retina of the eye and comprising a refractive, diffractive, or reflective structure; anda third structure to direct light to the retina of the eye, the third structure configured to be located more anterior to the anterior surface of the eye than the light source and comprising a reflective structure;wherein the light source and the second structure are configured to concentrate the light energy on the retina of the eye with an irradiance on the retina within a range from 0.1 mW/cm2 to 5 mW/cm2 to treat the refractive error of the eye.
  • 2. The apparatus of claim 1, wherein the light source emits violet light.
  • 3. The apparatus of claim 1, wherein the first structure comprises a contact lens.
  • 4. The apparatus of claim 3, wherein the contact lens comprises a lens body, the lens body comprising one or more of a soft contact lens, a hydrogel contact lens, a hard contact lens, a rigid gas permeable contact lens, a polymethyl methacrylate contact lens, or an orthokeratology contact lens.
  • 5. The apparatus of claim 3, wherein the light energy comprises violet light energy and the contact lens is configured to direct the violet light energy onto a cornea and toward the retina with an amount sufficient to promote a curvature change to the cornea of the eye.
  • 6. The apparatus of claim 1, wherein the light energy comprises violet light energy comprising a wavelength within a range from 360 nm to 400 nm.
  • 7. The apparatus of claim 1, wherein the light energy comprises violet light energy and the light source is configured to direct the violet light energy to the retina.
  • 8. The apparatus of claim 1, wherein the light source illuminates a pupil of the eye with the light energy in a range from 0.1 nit to 10 nits.
  • 9. The apparatus of claim 1, wherein the first structure comprises a contact lens comprising a posterior surface comprising a posterior radius of curvature sized to fit a cornea of the eye, and an anterior surface comprising an anterior radius of curvature configured to correct vision of the eye.
  • 10. The apparatus of claim 1, wherein the structure to contact the eye comprises an implantable structure and wherein the implantable structure comprises a covering disposed over the light source.
  • 11. The apparatus of claim 1, wherein the light source comprises one or more of a radioluminescent light source, a light emitting diode, a laser diode, a radioactive material, or a phosphorescent material.
  • 12. The apparatus of claim 1, wherein the structure to contact the eye comprises an optically transmissive material comprising a transmittance of at least 40% at 360 nm.
  • 13. The apparatus of claim 1, wherein the light source is arranged in a pattern on the structure to contact the eye, the pattern comprising one or more of: a spatial pattern on the structure to contact the eye, a spatial pattern located on an optically used portion of a contact lens, a spatial pattern on an inner portion of the contact lens to transmit light to the retina when a pupil constricts, a circular pattern, or a radial pattern.
  • 14. The apparatus of claim 1, wherein the apparatus comprises a contact lens comprising a posterior surface shaped to receive a cornea of the eye, a contact lens material comprising an index of refraction configured to transmit violet light from the source toward the retina, the contact lens comprising an anterior surface shaped to correct a refractive error of the eye in combination with the index of refraction and the posterior surface.
  • 15. A method, the method comprising treating an eye with the apparatus of claim 1.
CROSS REFERENCE

This application is a 371 national phase of PCT/US2019/030682, filed May 3, 2019, and claims the benefit under 35 U.S.C. § 119 (e) of United States Provisional Application No. 62/669,580, filed May 10, 2018, entitled “METHODS AND APPARATUSES OF TREATING REFRACTIVE ERROR OF THE EYE”, the disclosures of which are incorporated, in their entirety, by this reference.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2019/030682 5/3/2019 WO
Publishing Document Publishing Date Country Kind
WO2019/217241 11/14/2019 WO A
US Referenced Citations (203)
Number Name Date Kind
2350386 Christman Jun 1944 A
6516808 Schulman Feb 2003 B2
7018040 Blum Mar 2006 B2
8057034 Ho Nov 2011 B2
8246167 Legerton Aug 2012 B2
8432124 Foster Apr 2013 B2
8662664 Artal Soriano Mar 2014 B2
8857983 Pugh Oct 2014 B2
8960899 Etzkorn Feb 2015 B2
9054079 Etzkorn Jun 2015 B2
9176332 Etzkorn Nov 2015 B1
9345813 Hogg May 2016 B2
9482882 Hanover Nov 2016 B1
9482883 Meisenholder Nov 2016 B1
9726904 Lin Aug 2017 B1
9763827 Kelleher Sep 2017 B2
9885884 Drobe Feb 2018 B2
9889615 Pugh Feb 2018 B2
9918894 Lam Mar 2018 B2
9962071 Yates May 2018 B2
10133092 Tsubota Nov 2018 B2
10139521 Tran Nov 2018 B2
10146067 Tsai Dec 2018 B2
10231897 Tse Mar 2019 B2
10268050 To Apr 2019 B2
10359648 Kim Jul 2019 B2
10591745 Lin Mar 2020 B1
10788686 Tsai Sep 2020 B2
10884264 Hones Jan 2021 B2
10921612 Zhou Feb 2021 B2
10993515 Kim May 2021 B1
11000186 Linder May 2021 B2
11187921 Zhou Nov 2021 B2
11219287 Kim Jan 2022 B1
11275259 Kubota Mar 2022 B2
11281022 Buscemi Mar 2022 B2
11320674 Kubota May 2022 B2
11358001 Kubota Jun 2022 B2
11366339 Kubota Jun 2022 B2
11366341 Kubota Jun 2022 B1
11388968 Dabov Jul 2022 B2
11395959 Stemple Jul 2022 B2
11402662 Wyss Aug 2022 B2
11409136 Kubota Aug 2022 B1
11415818 Olgun Aug 2022 B2
11444488 Bohn Sep 2022 B2
11446514 Bahmani Sep 2022 B2
11460720 Kubota Oct 2022 B1
11467423 Buscemi Oct 2022 B2
11467426 Kubota Oct 2022 B2
11467428 Kubota Oct 2022 B2
11470936 Kim Oct 2022 B2
11480813 Kubota Oct 2022 B2
11531216 Kubota Dec 2022 B2
11583696 Kubota Feb 2023 B2
11619831 Wyss Apr 2023 B2
11630329 Kubota Apr 2023 B2
11656483 Ice May 2023 B2
11681162 Zhou Jun 2023 B2
11681164 Jamshidi Jun 2023 B2
11693259 Buscemi Jul 2023 B2
11719957 Kubota Aug 2023 B2
11733545 Kubota Aug 2023 B2
11777340 Kubota Oct 2023 B2
11971615 Kubota Apr 2024 B2
11986669 Kubota May 2024 B2
20020186345 Duppstadt Dec 2002 A1
20040237971 Radhakrishnan Dec 2004 A1
20050258053 Sieg Nov 2005 A1
20060082729 To Apr 2006 A1
20060227067 Iwasaki Oct 2006 A1
20070115431 Smith, III May 2007 A1
20070153231 Iuliano Jul 2007 A1
20070281752 Lewis Dec 2007 A1
20080231799 Iuliano Sep 2008 A1
20080231801 Iuliano Sep 2008 A1
20080291391 Meyers Nov 2008 A1
20080309882 Thorn Dec 2008 A1
20090187242 Weeber Jul 2009 A1
20090201460 Blum Aug 2009 A1
20090204207 Blum Aug 2009 A1
20100076417 Suckewer Mar 2010 A1
20100294675 Mangano Nov 2010 A1
20100296058 Ho Nov 2010 A1
20110085129 Legerton Apr 2011 A1
20110153012 Legerton Jun 2011 A1
20110202114 Kessel Aug 2011 A1
20120055817 Newman Mar 2012 A1
20120199995 Pugh Aug 2012 A1
20120206485 Osterhout Aug 2012 A1
20120212399 Border Aug 2012 A1
20120215291 Pugh Aug 2012 A1
20130027655 Blum Jan 2013 A1
20130072828 Sweis Mar 2013 A1
20130135578 Pugh May 2013 A1
20130194540 Pugh Aug 2013 A1
20130278887 Legerton Oct 2013 A1
20130317487 Luttrull Nov 2013 A1
20140039361 Siu Feb 2014 A1
20140085601 Etzkorn Mar 2014 A1
20140194773 Pletcher Jul 2014 A1
20140218647 Blum Aug 2014 A1
20140240665 Pugh Aug 2014 A1
20140268029 Pugh Sep 2014 A1
20140277291 Pugh Sep 2014 A1
20140306361 Pugh Oct 2014 A1
20140379054 Cooper et al. Dec 2014 A1
20150018599 Legerton Jan 2015 A1
20150057701 Kelleher Feb 2015 A1
20150109574 Tse Apr 2015 A1
20150160477 Dai Jun 2015 A1
20150200554 Marks Jul 2015 A1
20150241706 Schowengerdt Aug 2015 A1
20160016004 Hudson Jan 2016 A1
20160056498 Flitsch Feb 2016 A1
20160067037 Rosen Mar 2016 A1
20160067087 Tedford Mar 2016 A1
20160091737 Kim Mar 2016 A1
20160143801 Yin May 2016 A1
20160158486 Colbaugh Jun 2016 A1
20160270656 Samec Sep 2016 A1
20160299357 Hayashi Oct 2016 A1
20160377884 Lau Dec 2016 A1
20170000326 Samec Jan 2017 A1
20170001032 Samec Jan 2017 A1
20170010480 Blum Jan 2017 A1
20170014074 Etzkorn Jan 2017 A1
20170055823 Lu Mar 2017 A1
20170072218 Rucker Mar 2017 A1
20170115512 Pugh Apr 2017 A1
20170184875 Newman Jun 2017 A1
20170270636 Shtukater Sep 2017 A1
20170276963 Brennan Sep 2017 A1
20170307779 Marullo Oct 2017 A1
20170367879 Lopath Dec 2017 A1
20180017810 Wu Jan 2018 A1
20180017814 Tuan Jan 2018 A1
20180052319 Mccabe Feb 2018 A1
20180055351 Yates Mar 2018 A1
20180074322 Rousseau Mar 2018 A1
20180090958 Steger Mar 2018 A1
20180092738 Tai Apr 2018 A1
20180136486 Macnamara May 2018 A1
20180136491 Ashwood May 2018 A1
20180161231 Tse Jun 2018 A1
20180173010 Harant Jun 2018 A1
20180188556 Portney Jul 2018 A1
20180221140 Rosen Aug 2018 A1
20180264284 Alvarez Sep 2018 A1
20180275427 Lau Sep 2018 A1
20180345034 Butzloff Dec 2018 A1
20190033618 Choi Jan 2019 A1
20190033619 Neitz Jan 2019 A1
20190049730 Miller Feb 2019 A1
20190076241 Alarcon Heredia Mar 2019 A1
20190092545 Oag Mar 2019 A1
20190129204 Tsubota May 2019 A1
20190227342 Brennan Jul 2019 A1
20190235279 Hones Aug 2019 A1
20190247675 Legerton Aug 2019 A1
20190250413 Martin Aug 2019 A1
20190250432 Kim Aug 2019 A1
20190314147 Blum Oct 2019 A1
20190318589 Howell Oct 2019 A1
20200026082 Park Jan 2020 A1
20200033637 Jamshidi Jan 2020 A1
20200073148 Alhaideri Mar 2020 A1
20200089023 Zhou Mar 2020 A1
20200108272 Bahmani Apr 2020 A1
20200110265 Serdarevic Apr 2020 A1
20200133024 Paune Fabre Apr 2020 A1
20200142219 Rousseau May 2020 A1
20200264455 Olgun Aug 2020 A1
20200364992 Howell Nov 2020 A1
20210018762 Zheleznyak Jan 2021 A1
20210031051 Kubota Feb 2021 A1
20210048690 Guillot Feb 2021 A1
20210231977 Zhou Jul 2021 A1
20210263336 Gupta Aug 2021 A1
20210298440 Kim Sep 2021 A1
20210329764 Linder Oct 2021 A1
20210356767 Kubota Nov 2021 A1
20210376661 Bohn Dec 2021 A1
20210379399 Buscemi Dec 2021 A1
20210382325 Kubota Dec 2021 A1
20210382326 Kubota Dec 2021 A1
20210389607 Buscemi Dec 2021 A1
20220057651 Segre Feb 2022 A1
20220107508 Zhou Apr 2022 A1
20220128842 Ice Apr 2022 A1
20220179213 Zhou Jun 2022 A1
20220197059 Zhou Jun 2022 A1
20220231523 Bristol Jul 2022 A1
20220257972 Kubota Aug 2022 A1
20220299795 Wyss Sep 2022 A1
20220390766 Kubota Dec 2022 A1
20220390768 Kubota Dec 2022 A1
20220397775 Bahmani Dec 2022 A1
20220404641 Kubota Dec 2022 A1
20220413318 Kubota Dec 2022 A1
20230026567 Buscemi Jan 2023 A1
20230089006 Kubota Mar 2023 A1
20230324717 Kubota Oct 2023 A1
Foreign Referenced Citations (93)
Number Date Country
215494397 Jan 2022 CN
3153139 Apr 2017 EP
3232254 Oct 2017 EP
3255478 Dec 2017 EP
3413116 Dec 2018 EP
3640713 Apr 2020 EP
2006292883 Oct 2006 JP
2011518355 Jun 2011 JP
2014508585 Apr 2014 JP
2017173847 Sep 2017 JP
2017219847 Dec 2017 JP
20180038359 Apr 2018 KR
20180038359 Apr 2018 KR
M356929 May 2009 TW
201234072 Aug 2012 TW
201734580 Oct 2017 TW
2009074638 Jun 2009 WO
2009074638 Jun 2009 WO
2009121810 Oct 2009 WO
2009129528 Oct 2009 WO
2010015255 Feb 2010 WO
2010043599 Apr 2010 WO
2011008846 Jan 2011 WO
2011089042 Jul 2011 WO
2011153158 Dec 2011 WO
2011163559 Dec 2011 WO
2012018583 Feb 2012 WO
2012037019 Mar 2012 WO
2012106542 Aug 2012 WO
2012118777 Sep 2012 WO
2012129210 Sep 2012 WO
2012136470 Oct 2012 WO
2012138426 Oct 2012 WO
2013059195 Apr 2013 WO
2013059656 Apr 2013 WO
2013059663 Apr 2013 WO
2013087518 Jun 2013 WO
2013112748 Aug 2013 WO
2013112803 Aug 2013 WO
2013112862 Aug 2013 WO
2013112868 Aug 2013 WO
2013130803 Sep 2013 WO
2013151728 Oct 2013 WO
2014004836 Jan 2014 WO
2014004839 Jan 2014 WO
2014018104 Jan 2014 WO
2014033035 Mar 2014 WO
2014050879 Apr 2014 WO
2014052012 Apr 2014 WO
2014117173 Jul 2014 WO
2014120928 Aug 2014 WO
2014161002 Oct 2014 WO
2014178221 Nov 2014 WO
2014191460 Dec 2014 WO
2015063097 May 2015 WO
2015095891 Jun 2015 WO
2015105881 Jul 2015 WO
2015164564 Oct 2015 WO
2015186723 Dec 2015 WO
2016019346 Feb 2016 WO
2016019351 Feb 2016 WO
2017039672 Mar 2017 WO
2017083770 May 2017 WO
2017083774 May 2017 WO
2017094886 Jun 2017 WO
2017168122 Oct 2017 WO
2018014712 Jan 2018 WO
2018014712 Jan 2018 WO
2018014960 Jan 2018 WO
2018057804 Mar 2018 WO
2018075229 Apr 2018 WO
2018085576 May 2018 WO
2018088980 May 2018 WO
2018089699 May 2018 WO
2018208724 Nov 2018 WO
2019100941 May 2019 WO
2019114463 Jun 2019 WO
2019191510 Oct 2019 WO
2019217241 Nov 2019 WO
2020014074 Jan 2020 WO
2020014613 Jan 2020 WO
2020025355 Feb 2020 WO
2020028177 Feb 2020 WO
2020069232 Apr 2020 WO
2021056018 Mar 2021 WO
2021116449 Jun 2021 WO
2021168481 Aug 2021 WO
2021231684 Nov 2021 WO
2021252318 Dec 2021 WO
2021252319 Dec 2021 WO
2021252320 Dec 2021 WO
2022217193 Oct 2022 WO
2022258572 Dec 2022 WO
Non-Patent Literature Citations (60)
Entry
International Search Report and Written Opinion for International Application No. PCT/US2019/030682, 8 pages (Jul. 17, 2019).
Lam, Carly Siu Yin, et al., “Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial,” Br. J. Ophthalmol. 0:1-6 (2019).
Torii, Hidemasa, et al., “Violet Light Exposure Can Be a Preventive Strategy Against Myopia Progression,” EBioMedicine 15:210-219 (2017).
Adler, Daniel, et al., “The possible effect of under correction on myopic progression in children.” Clin Exp Optom., 89:315-321 (2006).
Aleman, Andrea C., et al.,, “Reading and Myopia: Contrast Polarity Matters,” Scientific Reports, 8 pages (2018).
Arden, G.B., et al., “Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis,” Vision Research 38:1723-1729 (1998).
Arden, GB, et al, “Regression of early diabetic macular edema is associated with prevention of dark adaptation”, in Eye, (2011). 25, pp. 1546-1554.
Benavente-Perez, A., et al., “Axial Eye Growth and Refractive Error Development Can be Modified by Exposing the Peripheral Retina to Relative Myopic or Hyperopic Defocus,” Invest Ophthalmol Vis Sci., 55:6765-6773 (2014).
Bonar, Jr, et al, “High brightness low power consumption microLED arrays”, in SPIE DigitalLibrary.org/conference-proceedings-of-spie, SPIE OPTO, 2016, San Francisco, California, United States, Abstract Only.
Carr, Brittany J., et al., “The Science Behind Myopia,” retrieved from https://webvision.med.utah.edu/book/part-xvii-refractive-errors/the-science-behind-myopia-by-brittany-j-carr-and-william-k-stell/, 89 pages (2018).
Chakraborty, R., et al., “Diurnal Variations in Axial Length, Choroidal Thickness, Intraocular Pressure, and Ocular Biometrics,” IOVS, 52(8):5121-5129 (2011).
Chakraborty, R., et al., “Hyperopic Defocus and Diurnal Changes in Human Choroid and Axial Length,” Optometry and Visual Science, 90(11):1187-1198 (2013).
Chakraborty, R., et al., “Monocular Myopic Defocus and Daily Changes in Axial Length and Choroidal Thickness of human Eyes,” Exp Eye Res, 103:47-54 (2012).
Cooper, J., et al, “Current status of the development and treatment of myopia”, Optometry, 83:179-199 (2012).
Cooper, J., et al., “A Review of Current Concepts of the Etiology and Treatment of Myopia,” Eye & Contact Lens, 44(4):231-247 (Jul. 2018).
Demory, B., et al, “Integrated parabolic microlenses on micro LED color pixels”, in Nanotechnology, (2018); 29, 16, pp. 1018, Abstract Only.
Dolgin, Elle, “The Myopia Boom,” Nature 519:276-278 (2015).
Edrington, Timothy B., “A literature review: The impact of rotational stabilization methods on toric soft contact lens performance,” Contact Lens & Anterior Eye, 34:104-110 (2011).
Flitcroft, D.I., “The complex interactions of retinal, optical and environmental factors in myopia aetiology,” 31(6):622-660 (2012).
Garner, L.F., et al., “Crystalline Lens Power in Myopia,” Optometry and Vision Science, 69:863-865 (1992).
Gwiazda, Jane, “Treatment Options for Myopia,” retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729053/, Optom Vis Sci., 86(6):624-628 (Jun. 2009).
Gwiazda, Jane, et al, “A Randomized Clinical Trial of Progressive Addition Lenses versus Single Vision Lenses on the Progression of Myopia in Children”, Invest Ophthalmol Vis Scl, 44:1492-500 [PubMed: 12657584] (2003).
Hammond, D.S., et al, “Dynamics of active emmetropisation in young chicks—influence of sign and magnitude of imposed defocus” Ophthalmic Physiol Opt. 33:215-222 (2013).
Henry W., “MicroLED Sources enable diverse ultra-low power applications”, in Photonic Spectra, 2013.
Jones, D., “Measure Axial Length to Guide Myopia Management,” Review of Myopia Management, 5 pages (Apr. 9, 2020).
Kur, Joanna, et al., “Light adaptation does not prevent early retinal abnormalities in diabetic rats,” Scientific Reports, 8 pages (Feb. 8, 2016).
Lagreze, Wolf A., et al., “Preventing Myopia,” retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615392/, Dtsch Arztebl Int., 114(35-36):575-580 (Sep. 2017).
Leo, Seo-Wei, et al., “An evidence-based update on myopia and interventions to retard its progression,” J AAPOS, 15(2): 181-189 (Apr. 2011).
Lingley, A.R., et al, : A single pixel wireless contact lens display, in J Micromech. Microeng., 2011; 21, 125014; doi:10.1088/0960-1317/21/12/125014, Abstract Only.
Martin, J.A., et al., “Predicting and Assessing Visual Performance with Multizone Bifocal Contact Lenses,” Optom Vis Sci, 80(12):812-819 (2003).
Matkovic, K., et al., “Global Contrast Factor—a New Approach to Image Contrast,” Computational Aesthetics in Graphics, Visualization and Imaging, 9 pages (2005).
McKeague C, et al. “Low-level night-time light therapy for age-related macular degeneration (ALight): study protocol for a randomized controlled trial”, in Trials 2014, 15:246, http://www.trialsjournal.com/content/15/1/246.
Moreno, I, “Creating a desired lighting pattern with an LED array” in Aug. 2008, Proceedings of SPIE—The International Society for Optical Engineering 7058, DOI: 10.1117/12.795673.
Moreno, I., “Modeling the radiation pattern of LEDS”, in Optics Express, 2008; 16, 3 pp. 1808.
Nickla, Debora L., et al., “Brief hyperopic defocus or form deprivation have varying effects on eye growth and ocular rhythms depending on the time-of-day of exposure,” Exp Eye Res. 161:132-142 (Aug. 2017).
Ramsey, DJ, and Arden, GB, “Hypoxia and dark adaptation in diabetic retinopathy: Interactions, consequences and therapy”, in Microvascular Complications-Retinopathy (JK Sun, ed.), Cur Dab Rep (2015) 15: 118, DOI 10.1007/s11892-015-0686-2, Abstract Only.
Read, Scott A., et al., “Choroidal changes in human myopia: Insights from optical coherence tomography imaging,” Clin Exp Optom, 16 pages (2018).
Read, Scott A., et al., “Human Optical Axial Length and Defocus,” IOVS, 51(12):6262-6269 (2010).
Shivaprasad, S, et al, “Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial,” in www.thelancet.com/diabetes-endocrinology vol. 6, pp. 382-391 ( May 2018).
Smith, III, Earl L., “Optical treatment strategies to slow myopia progression: Effects of the visual extent of the optical treatment zone,” retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624048/, Exp Eye Res., 114:77-88 (Sep. 2013).
Srinivasan, S., “Ocular axes and angles: Time for better understanding,” J. Cataract Refract. Surg., 42:351-352 (Mar. 2016).
Wallman, Josh, et al., “Homeostasis of Eye Growth and the Question of Myopia,” Neuron, 43:447-468 (2004).
Wolffsohn, James A., et al., “Impact of Soft Contact Lens Edge Design and Midperipheral Lens Shape on the Epithelium and Its Indentation With Lens Mobility,” IOVS, 54(9):6190-6196 (2013).
Haglund, Erik, et al., “Multi-wavelength VCSEL arrays using high-contrast gratings,” Proc. of SPIE vol. 10113, 7 pages (2017).
International Application No. PCT/US2021/036100, filedJune 7, 2021 (86 pages).
International Patent Application No. PCT/US2021/032162, filed May 13, 2021 (58 pages).
International Patent Application No. PCT/US2021/036102, filed Jun. 7, 2021 (67 pages).
International Patent Application No. PCT/US2021/070166, filed Feb. 19, 2021 (79 pages).
Jayaraman, V., et al., “Recent Advances in MEMS-VCSELs for High Performance Structural and Functional SS-OCT Imaging,” Proc. of SPIE vol. 8934, retrieved from http://proceedings.spiedigitallibrary.org/ on Dec. 1, 2015 (2014).
U.S. Appl. No. 17/304,666, filed Jun. 24, 2021 (67 pages).
U.S. Appl. No. 17/302,479, filed May 4, 2021 (60 pages).
U.S. Appl. No. 17/302,827, filed May 13, 2021 (52 pages).
U.S. Appl. No. 17/303,889, filed Jun. 9, 2021 (69 pages).
U.S. Appl. No. 17/304,630, filed Jun. 23, 2021 (68 pages).
U.S. Appl. No. 17/304,691, filed Jun. 24, 2021 (88 pages).
Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Prog Retin Eye Res. Jul. 2021; 83:100923. Epub Nov. 27, 2020.
Walline JJ, Lindsley K, Vedula SS, Cotter SA, Mutti DO, Twelker JD. Interventions to slow progression of myopia in children. Cochran Database Syst Rev. Dec. 7, 2011; (12):CD004916.
Zhou WJ, Zhang YY, Li H, Wu YF, Xu J, Lv S, Li G, Liu SC, Song SF. Five-year progression of refractive errors and incidence of myopia in school-aged children in western China. J Epidemiol. Jul. 5, 2016; 26(7):386-95. Epub Feb. 13, 2016.
“Design Considerations for Overmolding and Insert Molding,” Proto Labs, retrieved May 6, 2024 from chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://vertassets.blob.core.windows.net/download/777c536d/777c536d-f935-4a3a-aa9e-bff37143c1dd/pl_designconsiderations_for_om_im_wp_final.pdf, applicant believes that the teachings of this reference was known prior to Apr. 6, 2021.
“What Is Insert Molding? Process, Considerations & Applications,” retrieved May 6, 2024 from https://www.rapiddirect.com/blog/what-is-insert-molding/, applicant believes that the teachings of these reference was known prior to Apr. 6, 2021.
Related Publications (1)
Number Date Country
20210069524 A1 Mar 2021 US
Provisional Applications (1)
Number Date Country
62669580 May 2018 US